.Some opportunities happen only once in a lifetime - like a job where you have the chance to change lives. At Alexion, people living with rare and devastating diseases are our Guiding Star. We are driven to continuously innovate and create meaningful value in all we do to help patients and families fully live their best lives. We value the uniqueness and diversity of our employees and recognize that nurturing the diverse perspectives and strengths of our people translates into innovative breakthroughs for patients.Director International Health Economics & Outcomes Research (HEOR) - Germany, France, Spain and Turkey LOCATION: SPAINREPORTS TO: SENIOR DIRECTOR HEOR, HEAD OF THE INTERNATIONAL & JAPAN REGIONThis is what you will do:The Director International Health Economics and Outcomes Research (HEOR) is responsible for the strategic development and execution of health economics and outcomes research strategies to support access of Alexion products across the therapeutic disease areas for Germany, France, Spain and Turkey. The position will be based in the Alexion research facility in Barcelona, Spain or Dublin Ireland. The position is part of the Global HEOR team. Through key leadership and partnership across cross-functional teams, the job holder embeds global HEOR strategy into broader disease area and clinical development strategies. This collaboration builds strategies to demonstrate and differentiate the value proposition and corresponding scientific evidence of Alexion products for payers, patients, clinical institutions and other key influencers.This role reports directly to the Senior Director HEOR, Head International & Japan.You will be responsible for:Utilizes in-depth knowledge of disease area and portfolio strategy in combination with health economics and outcomes research to execute and tailor the HEOR strategy and tactics for Germany, France, Spain and Turkey in close collaboration with medical affairs, market access and commercial.Ensures payer/HTA relevant endpoints and evidence generation strategies are implemented throughout the product lifecycle.Accountable for the following:Builds collaborative relationships with cross-functional leaders across Medical Affairs, Commercial, Market Access, and Patient Advocacy within the French, German and Turkish affiliates to maximize evidence generation efforts to optimize launch and sustained reimbursement throughout the product lifecycle.Partners with the GHEOR Therapeutic Area (TA) heads to develop TA business strategies and clinical development plans that will provide a competitive advantage to differentiated payer & HTA evidence; drives efficient and innovative HEOR study development and study execution and dissemination to support the needs of the German, French, Spain and Turkish affiliates